Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Sues FDA After Agency Denies Pediatric Exclusivity for SENSIPAR
Amgen Sues FDA After Agency Denies Pediatric Exclusivity for SENSIPAR
Amgen Sues FDA After Agency Denies Pediatric Exclusivity for SENSIPAR
Submitted by
admin
on May 31, 2017 - 9:28am
Source:
FDA Law Blog
News Tags:
Amgen
FDA
pediatric exclusivity
Sensipar
patents
chronic kidney disease
Headline:
Amgen Sues FDA After Agency Denies Pediatric Exclusivity for SENSIPAR
Do Not Allow Advertisers to Use My Personal information
